-
1
-
-
0032500641
-
Characterization of two human genes encoding acyl coenzyme A: Cholesterol acyltransferase-related enzymes
-
OELKERS P, BEHARI A, CROMLEY D, BILLHEIMER JT, STURLEY SL: Characterization of two human genes encoding acyl coenzyme A: Cholesterol acyltransferase-related enzymes. J Biol. Chem. (1998) 273(41):26765-26771.
-
(1998)
J Biol. Chem
, vol.273
, Issue.41
, pp. 26765-26771
-
-
Oelkers, P.1
Behari, A.2
Cromley, D.3
Billheimer, J.T.4
Sturley, S.L.5
-
2
-
-
0027527733
-
Molecular cloning and functional expression of human acylcoenzyme A-cholesterol acyltransferase cDNA in mutant Chinese hamster ovary cells
-
CHANG CCY, HUH HY, CADIGAN KM, CHANG TY: Molecular cloning and functional expression of human acylcoenzyme A-cholesterol acyltransferase cDNA in mutant Chinese hamster ovary cells. J. Biol. Chem. (1993) 268:20747-20755.
-
(1993)
J. Biol. Chem
, vol.268
, pp. 20747-20755
-
-
Chang, C.C.Y.1
Huh, H.Y.2
Cadigan, K.M.3
Chang, T.Y.4
-
3
-
-
0031668254
-
Expression of ACAT-1 protein in human atherosclerotic lesions and cultured human monocytes-macrophages
-
MIYAZAKI A, SAKASHITA N, LEE O et al. Expression of ACAT-1 protein in human atherosclerotic lesions and cultured human monocytes-macrophages. Arterioscler. Thromb. Vasc. Biol. (1998) 18(10):1568-1574.
-
(1998)
Arterioscler. Thromb. Vasc. Biol
, vol.18
, Issue.10
, pp. 1568-1574
-
-
Miyazaki, A.1
Sakashita, N.2
Lee, O.3
-
4
-
-
15444348784
-
ACAT-2, a second mammalian acyl-CoA:cholesterol acyltransferase - Its cloning, expression, and characterization
-
CASES S, NOVAK S, ZHENG YW et al.: ACAT-2, a second mammalian acyl-CoA:cholesterol acyltransferase - Its cloning, expression, and characterization. J. Biol. Chem. (1998) 273(41):26755-26764.
-
(1998)
J. Biol. Chem
, vol.273
, Issue.41
, pp. 26755-26764
-
-
Cases, S.1
Novak, S.2
Zheng, Y.W.3
-
5
-
-
0032500649
-
Identification of a form of acyl-CoA:cholesterol acyltransferase specific to liver and intestine in nonhuman primates
-
ANDERSON RA, JOYCE C, DAVIS M et al: Identification of a form of acyl-CoA:cholesterol acyltransferase specific to liver and intestine in nonhuman primates. J. Biol. Chem. (1998) 273(41):26747-26754.
-
(1998)
J. Biol. Chem
, vol.273
, Issue.41
, pp. 26747-26754
-
-
Anderson, R.A.1
Joyce, C.2
Davis, M.3
-
6
-
-
0032478235
-
Relationship between bioavailability and hypocholesterolemic activity of YM17E, an inhibitor of ACAT, in cholesterol-fed rats
-
UCHIDA T, AOYAMA K, WATANABE T, HIGUCHI S: Relationship between bioavailability and hypocholesterolemic activity of YM17E, an inhibitor of ACAT, in cholesterol-fed rats. Atherosclerosis (1998) 137(1):97-106.
-
(1998)
Atherosclerosis
, vol.137
, Issue.1
, pp. 97-106
-
-
Uchida, T.1
Aoyama, K.2
Watanabe, T.3
Higuchi, S.4
-
7
-
-
0345411397
-
A selective inhibitor of intestinal ACAT, EAB309 suppresses both intestinal and hepatic cholesterol output and stimulates chylomicron removal
-
UMEDA Y, HIRANO T, KAKO Y, KAMAGATA K, OKUYAMA K, SUZUKI K: A selective inhibitor of intestinal ACAT, EAB309 suppresses both intestinal and hepatic cholesterol output and stimulates chylomicron removal. Life Sci. (1998) 63(13):187-195.
-
(1998)
Life Sci
, vol.63
, Issue.13
, pp. 187-195
-
-
Umeda, Y.1
Hirano, T.2
Kako, Y.3
Kamagata, K.4
Okuyama, K.5
Suzuki, K.6
-
8
-
-
0011452376
-
Factors facilitating cholesterol absorption from the intestine via lymphatic pathways
-
VAHOUNY GV, FAWAL I, TREADWELL CR: Factors facilitating cholesterol absorption from the intestine via lymphatic pathways. Am. J. Physiol. (1957) 188:742-746.
-
(1957)
Am. J. Physiol
, vol.188
, pp. 742-746
-
-
Vahouny, G.V.1
Fawal, I.2
Treadwell, C.R.3
-
9
-
-
0022256566
-
Role of acyl-CoA-cholesterol acyl-transferase in cellular cholesterol metabolism
-
SUCKLING KE, STANGE EF: Role of acyl-CoA-cholesterol acyl-transferase in cellular cholesterol metabolism. J. Lipid Res. (1985) 26:647-671.
-
(1985)
J. Lipid Res
, vol.26
, pp. 647-671
-
-
Suckling, K.E.1
Stange, E.F.2
-
10
-
-
0021043541
-
Role of acyl CoA:cholesterol acyltransferase in cholesterol absorption and its inhibition of 57-118 in the rabbit
-
HEIDER JG, PICKENS CE, KELLY LA: Role of acyl CoA:cholesterol acyltransferase in cholesterol absorption and its inhibition of 57-118 in the rabbit. J. Lipid Res. (1983) 24:1127-1134.
-
(1983)
J. Lipid Res
, vol.24
, pp. 1127-1134
-
-
Heider, J.G.1
Pickens, C.E.2
Kelly, L.A.3
-
11
-
-
0021367211
-
Reduced cholesterol transmucosal transport in rats with inhibited mucosal acyl CoA:cholesterol acyltransferase and normal pancreatic function
-
BENNETT CS, TERCYAK AM: Reduced cholesterol transmucosal transport in rats with inhibited mucosal acyl CoA:cholesterol acyltransferase and normal pancreatic function. J. Lipid Res. (1984) 25:148-159.
-
(1984)
J. Lipid Res
, vol.25
, pp. 148-159
-
-
Bennett, C.S.1
Tercyak, A.M.2
-
12
-
-
0024389312
-
CL277082, a novel inhibitor of ACAT-catalyzed cholesterol esterification and cholesterol absorption
-
LARGIS EE, WANG CH, DEVRIES VG, SCHAFFER SA: CL277082, a novel inhibitor of ACAT-catalyzed cholesterol esterification and cholesterol absorption. J. Lipid Res. (1989) 30:681-690.
-
(1989)
J. Lipid Res
, vol.30
, pp. 681-690
-
-
Largis, E.E.1
Wang, C.H.2
Devries, V.G.3
Schaffer, S.A.4
-
13
-
-
0031909066
-
Inhibition of acyl coenzyme A: Cholesterol acyltransferase blocks esterification but not uptake of cholesterol in Caco-2 cells
-
ELLSWORTH JL, STARR JR: Inhibition of acyl coenzyme A: cholesterol acyltransferase blocks esterification but not uptake of cholesterol in Caco-2 cells. Metabolism (1998) 47(3):325-332.
-
(1998)
Metabolism
, vol.47
, Issue.3
, pp. 325-332
-
-
Ellsworth, J.L.1
Starr, J.R.2
-
14
-
-
0036191526
-
Cholesterol esters regulate apo B48 secretion in CaCo2 cells
-
PALS S, ALLISTER E, THOMSON A, MAMO JC: Cholesterol esters regulate apo B48 secretion in CaCo2 cells. Atherosclerosis (2002) 161(1):55-63.
-
(2002)
Atherosclerosis
, vol.161
, Issue.1
, pp. 55-63
-
-
Pals, S.1
Allister, E.2
Thomson, A.3
Mamo, J.C.4
-
15
-
-
0011487723
-
The ACAT inhibitor avasimibe increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins
-
BURNETT JR, BARRETT PHR, TELFORD DE, HUFF MW. The ACAT inhibitor avasimibe increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins. Atherosclerosis (2000) 151:134.
-
(2000)
Atherosclerosis
, vol.151
, pp. 134
-
-
Burnett, J.R.1
Barrett, P.H.R.2
Telford, D.E.3
Huff, M.W.4
-
16
-
-
0036470894
-
Intracellular mechanisms mediating the inhibition of ApoB-containing lipoprotein synthesis and secretion in HepG2 cells by avasimibe (CI-1011), a novel acyl-coenzyme A:cholesterol acyltransferase (ACAT) inhibitor
-
TAGHIBIGLOU C, VAN IDERSTINE S, KULINSKI A, RUDY D, ADELI K: Intracellular mechanisms mediating the inhibition of ApoB-containing lipoprotein synthesis and secretion in HepG2 cells by avasimibe (CI-1011), a novel acyl-coenzyme A:cholesterol acyltransferase (ACAT) inhibitor. Biochem. Pharmacol. (2002) 63(3):349-360.
-
(2002)
Biochem. Pharmacol
, vol.63
, Issue.3
, pp. 349-360
-
-
Taghibiglou, C.1
Van Iderstine, S.2
Kulinski, A.3
Rudy, D.4
Adeli, K.5
-
17
-
-
0032769066
-
Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoprotein B production in miniature pigs
-
BURNETT JR, WILCOX LJ, TELFORD DE et al: Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoprotein B production in miniature pigs. J. Lipid Res. (1999) 40:1317-27.
-
(1999)
J. Lipid Res
, vol.40
, pp. 1317-1327
-
-
Burnett, J.R.1
Wilcox, L.J.2
Telford, D.E.3
-
18
-
-
0032918323
-
ApoB 100 secretion from HepG2 cells is decreased by the ACAT inhibitor CI-1011: An effect associated with enhanced intracellular degradation of apoB
-
WILCOX LJ, BARRETT PHR, NEWTON RS, HUFF MW: ApoB 100 secretion from HepG2 cells is decreased by the ACAT inhibitor CI-1011: an effect associated with enhanced intracellular degradation of apoB. Arterioscler. Thromb. Vasc. Biol. (1999) 19:939-949.
-
(1999)
Arterioscler. Thromb. Vasc. Biol
, vol.19
, pp. 939-949
-
-
Wilcox, L.J.1
Barrett, P.H.R.2
Newton, R.S.3
Huff, M.W.4
-
19
-
-
20644442234
-
Acyl-coenzyme A:cholesterol acyltransferase inhibitor, avasimibe, stimulates bile acid synthesis and cholesterol 7alpha-hydroxylase in cultured rat hepatocytes and in vivo in the rat
-
POST SM, ZOETEWEIJ JP, BOS MHA et al: Acyl-coenzyme A:cholesterol acyltransferase inhibitor, avasimibe, stimulates bile acid synthesis and cholesterol 7alpha-hydroxylase in cultured rat hepatocytes and in vivo in the rat. Hepatology (1999) 30(2):491-500.
-
(1999)
Hepatology
, vol.30
, Issue.2
, pp. 491-500
-
-
Post, S.M.1
Zoeteweij, J.P.2
Bos, M.H.A.3
-
20
-
-
0031668254
-
Expression of ACAT-1 protein in human atherosclerotic lesions and cultured human monocytes-macrophages
-
MIYAZAKI A, SAKASHITA N, LEE O et al: Expression of ACAT-1 protein in human atherosclerotic lesions and cultured human monocytes-macrophages. Arterioscler. Thromb. Vasc. Biol. (1998) 18(10):1568-1574.
-
(1998)
Arterioscler. Thromb. Vasc. Biol
, vol.18
, Issue.10
, pp. 1568-1574
-
-
Miyazaki, A.1
Sakashita, N.2
Lee, O.3
-
21
-
-
0001569096
-
The acyl-CoA:Cholesterol acyltransferase inhibitor, avasimibe, effectively limits lipid storage in human macrophages
-
RODRIGUEZ A, WEE SB, USHER DC: The acyl-CoA:Cholesterol acyltransferase inhibitor, avasimibe, effectively limits lipid storage in human macrophages. Circulation (1999) 100(18):I613.
-
(1999)
Circulation
, vol.100
, Issue.18
-
-
Rodriguez, A.1
Wee, S.B.2
Usher, D.C.3
-
22
-
-
0032469027
-
Stimulation of cholesterol release from rabbit foam cells by the action of a new inhibitor for acyl CoA:cholesterol acyltransferase (ACAT), HL-004
-
ISHII I, YOKOYAMA N, YANAGIMACHI M et al: Stimulation of cholesterol release from rabbit foam cells by the action of a new inhibitor for acyl CoA:cholesterol acyltransferase (ACAT), HL-004. J. Pharmacol. Exp. Therap. (1998) 287(1):115-121.
-
(1998)
J. Pharmacol. Exp. Therap
, vol.287
, Issue.1
, pp. 115-121
-
-
Ishii, I.1
Yokoyama, N.2
Yanagimachi, M.3
-
23
-
-
0035863037
-
Effects of high-density lipoprotein(2) on cholesterol transport and acyl-coenzyme A:cholesterol acyltransferase activity in P388D1 macrophages
-
LI L, POWNALL HJ: Effects of high-density lipoprotein(2) on cholesterol transport and acyl-coenzyme A:cholesterol acyltransferase activity in P388D1 macrophages. Biochem. Biophys. Acta (2001) 1530 (1):111-122.
-
(2001)
Biochem. Biophys. Acta
, vol.1530
, Issue.1
, pp. 111-122
-
-
Li, L.1
Pownall, H.J.2
-
24
-
-
0035799373
-
Acyl-CoA: Cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice
-
DELSING DJM, OFFERMAN EH, VAN DUYVENVOORDE W et al: Acyl-CoA: Cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice. Circulation (2001) 103:1778-1786.
-
(2001)
Circulation
, vol.103
, pp. 1778-1786
-
-
Delsing, D.J.M.1
Offerman, E.H.2
Van Duyvenvoorde, W.3
-
25
-
-
0032478324
-
The ACAT inhibitor, CI-1011, is effective in the prevention and regression of aortic fatty streak area in hamsters
-
NICOLOSI RJ, WILSON TA, KRAUSE BR: The ACAT inhibitor, CI-1011, is effective in the prevention and regression of aortic fatty streak area in hamsters. Atherosclerosis (1998) 137:77-85.
-
(1998)
Atherosclerosis
, vol.137
, pp. 77-85
-
-
Nicolosi, R.J.1
Wilson, T.A.2
Krause, B.R.3
-
26
-
-
0033972030
-
The ACAT inhibitor avasimibe reduces macrophages and matrix metalloproteinase expression in atherosclerotic lesions of hypercholesterolemic rabbits
-
BOCAN TMA, KRAUSE BR, ROSEBURY WS et al.: The ACAT inhibitor avasimibe reduces macrophages and matrix metalloproteinase expression in atherosclerotic lesions of hypercholesterolemic rabbits. Arterioscler. Thromb. Vasc. Biol. (2000) 20:70-79.
-
(2000)
Arterioscler. Thromb. Vasc. Biol
, vol.20
, pp. 70-79
-
-
Bocan, T.M.A.1
Krause, B.R.2
Rosebury, W.S.3
-
27
-
-
0034891581
-
Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice
-
CHIWATA T, ARAGANE K, FUJINAMI K et al: Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice. Br. J. Pharmacol. (2001) 133(7):1005-1012.
-
(2001)
Br. J. Pharmacol
, vol.133
, Issue.7
, pp. 1005-1012
-
-
Chiwata, T.1
Aragane, K.2
Fujinami, K.3
-
28
-
-
0035967492
-
Acyl-CoA-cholesterol acyltransferase inhibition reduces atherosclerosis in apolipoprotein E-deficient mice
-
KUSUNOKI J, HANSOTY DK, ARAGANE K, FALON JT, BADIMON JJ, FISHER EA: Acyl-CoA-cholesterol acyltransferase inhibition reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation (2001) 103(21):2604-2609.
-
(2001)
Circulation
, vol.103
, Issue.21
, pp. 2604-2609
-
-
Kusunoki, J.1
Hansoty, D.K.2
Aragane, K.3
Falon, J.T.4
Badimon, J.J.5
Fisher, E.A.6
-
29
-
-
0034898471
-
Effect of F-1394, an acyl-CoA: Cholesterol acyltransferase inhibitor, on atherosclerosis induced by high cholesterol diet in rabbits
-
ARAGANE K, KOJIMA K, FUJINAMI K, KAMEI J, KUSUNOKI J: Effect of F-1394, an acyl-CoA: cholesterol acyltransferase inhibitor, on atherosclerosis induced by high cholesterol diet in rabbits. Atherosclerosis (2001) 158(1):139-145.
-
(2001)
Atherosclerosis
, vol.158
, Issue.1
, pp. 139-145
-
-
Aragane, K.1
Kojima, K.2
Fujinami, K.3
Kamei, J.4
Kusunoki, J.5
-
30
-
-
0035063279
-
ACAT inhibitor F-1394 prevents intimal hyperplasia induced by balloon injury in rabbits
-
ARAGANE K, FUJINAMI K, KOJIMA K, KUSUNOKI J: ACAT inhibitor F-1394 prevents intimal hyperplasia induced by balloon injury in rabbits. J. Lipid Res. (2001) 42(2):480-488.
-
(2001)
J. Lipid Res
, vol.42
, Issue.2
, pp. 480-488
-
-
Aragane, K.1
Fujinami, K.2
Kojima, K.3
Kusunoki, J.4
-
31
-
-
0035004680
-
Pharmacological properties of R-755, a novel acyl-CoA:cholesterol acyltransferase inhibitor, in cholesterol-fed rats, hamsters and rabbits
-
MATSUI Y. HORIUCHI K, YAMAMOTO K, KANAI K: Pharmacological properties of R-755, a novel acyl-CoA:cholesterol acyltransferase inhibitor, in cholesterol-fed rats, hamsters and rabbits. Jpn. J. Pharmacol. (2001) 5(4):423-433.
-
(2001)
Jpn. J. Pharmacol
, vol.5
, Issue.4
, pp. 423-433
-
-
Matsui, Y.1
Horiuchi, K.2
Yamamoto, K.3
Kanai, K.4
-
32
-
-
0011395198
-
The effect of ACAT inhibition with avasimibe on vascular function in hypercholesterolemia
-
KURZ S, BORTHAYRE AB, HARRISON DG: The effect of ACAT inhibition with avasimibe on vascular function in hypercholesterolemia. Circulation (1998):I109-I110.
-
(1998)
Circulation
-
-
Kurz, S.1
Borthayre, A.B.2
Harrison, D.G.3
-
33
-
-
0032080223
-
Immunolocalization of acyl-coenzyme A: Cholesterol O-acyltransferase in macrophages
-
KHELEF N, BUTON X, BEATINI N et al: Immunolocalization of acyl-coenzyme A: Cholesterol O-acyltransferase in macrophages. J. Biol. Chem. (1998) 273(18):11218-11224.
-
(1998)
J. Biol. Chem
, vol.273
, Issue.18
, pp. 11218-11224
-
-
Khelef, N.1
Buton, X.2
Beatini, N.3
-
34
-
-
0036150483
-
Anti-atherosclerotic properties of the acyl-coenzyme A:cholesterol acyltransferase inhibitor F 12511 in casein-fed New Zealand rabbits
-
RIVAL Y, JUNQUERO D, BRUNIQUEL F et al.: Anti-atherosclerotic properties of the acyl-coenzyme A:cholesterol acyltransferase inhibitor F 12511 in casein-fed New Zealand rabbits. J. Cardiovasc. Pharmacol. (2002) 39(2):181-191.
-
(2002)
J. Cardiovasc. Pharmacol
, vol.39
, Issue.2
, pp. 181-191
-
-
Rival, Y.1
Junquero, D.2
Bruniquel, F.3
-
35
-
-
0032126266
-
HMG-CoA reductase and ACAT inhibitors act synergistically to lower plasma cholesterol and limit atherosclerotic lesion development in the cholesterol-fed rabbit
-
BOCAN TMA, MUELLER SB, BROWN EQ et al: HMG-CoA reductase and ACAT inhibitors act synergistically to lower plasma cholesterol and limit atherosclerotic lesion development in the cholesterol-fed rabbit. Atherosclerosis (1998) 139(1):21-30.
-
(1998)
Atherosclerosis
, vol.139
, Issue.1
, pp. 21-30
-
-
Bocan, T.M.A.1
Mueller, S.B.2
Brown, E.Q.3
-
36
-
-
0035116435
-
F 12511, a novel ACAT inhibitor, and atorvastatin regulate endogenous hypercholesterolemia in a synergistic manner in New Zealand rabbits fed a casein-enriched diet
-
JUNQUERO D, BRUNIQUEL F, N'GUYEN X et al: F 12511, a novel ACAT inhibitor, and atorvastatin regulate endogenous hypercholesterolemia in a synergistic manner in New Zealand rabbits fed a casein-enriched diet. Atherosclerosis (2001) 155(1):131-142.
-
(2001)
Atherosclerosis
, vol.155
, Issue.1
, pp. 131-142
-
-
Junquero, D.1
Bruniquel, F.2
N'Guyen, X.3
-
37
-
-
0034971344
-
Inhibition of both ACAT and HMG-CoA reductase may directly induce atherosclerotic lesion regression
-
BOCAN TMA, KRAUSE BR, ROSEBURY WS et al.: Inhibition of both ACAT and HMG-CoA reductase may directly induce atherosclerotic lesion regression. Atherosclerosis (2001) 157(1):97-105.
-
(2001)
Atherosclerosis
, vol.157
, Issue.1
, pp. 97-105
-
-
Bocan, T.M.A.1
Krause, B.R.2
Rosebury, W.S.3
-
38
-
-
0000298868
-
Serial evaluation of atherosclerosis with in vivo MRI: Study of atorvastatin and avasimibe in WHHL rabbits
-
WORTHLEY SG, HELFT G, OSENDE JI et al.: Serial evaluation of atherosclerosis with in vivo MRI: Study of atorvastatin and avasimibe in WHHL rabbits. Circulation (2000)102:II809.
-
(2000)
Circulation
, vol.102
-
-
Worthley, S.G.1
Helft, G.2
Osende, J.I.3
-
39
-
-
0028964742
-
Cell toxicity induced by inhibition of acyl coenzyme A: Cholesterol acyltransferase and accumulation of unesterified cholesterol
-
WARNER GJ, STOUDT G, BAMBERGER M et al: Cell toxicity induced by inhibition of acyl coenzyme A: cholesterol acyltransferase and accumulation of unesterified cholesterol. J. Biol. Chem. (1995) 270:5772-5778.
-
(1995)
J. Biol. Chem
, vol.270
, pp. 5772-5778
-
-
Warner, G.J.1
Stoudt, G.2
Bamberger, M.3
-
40
-
-
0031943893
-
Effects of intracellular free cholesterol accumulation on macrophage viability, a model for foam cell death
-
KELLNER-WEIBEL G, JERONE WG, SMALL DM et al.: Effects of intracellular free cholesterol accumulation on macrophage viability, a model for foam cell death. Arterioscler. Thromb. Vasc. Biol. (1998)18:423-431.
-
(1998)
Arterioscler. Thromb. Vasc. Biol
, vol.18
, pp. 423-431
-
-
Kellner-Weibel, G.1
Jerone, W.G.2
Small, D.M.3
-
41
-
-
0032868510
-
Novel effects of the acyl-coenzyme A: Cholesterol acyltransferase inhibitor 58-035 on foam cell development in primary human monocyte-derived macrophages
-
RODRIGUEZ A, BACHORIK PS, WEE SB: Novel effects of the acyl-coenzyme A: cholesterol acyltransferase inhibitor 58-035 on foam cell development in primary human monocyte-derived macrophages. Arterioscler. Thromb. Vasc. Biol. (1999)19:2199-2206.
-
(1999)
Arterioscler. Thromb. Vasc. Biol
, vol.19
, pp. 2199-2206
-
-
Rodriguez, A.1
Bachorik, P.S.2
Wee, S.B.3
-
42
-
-
0001569096
-
The acyl-CoA: Cholesterol acyltransferase inhibitor, avasimibe, effectively limits lipid storage in human macrophages
-
RODRIGUEZ A, WEE SK, USHER DC: The acyl-CoA: cholesterol acyltransferase inhibitor, avasimibe, effectively limits lipid storage in human macrophages. Circulation (1999) 100:613.
-
(1999)
Circulation
, vol.100
, pp. 613
-
-
Rodriguez, A.1
Wee, S.K.2
Usher, D.C.3
-
43
-
-
0030273663
-
Difference between normal and WHHL rabbits in susceptibility to the adrenal toxicity of an acyl-CoA:cholesterol acyltransferase inhibitor, FR 145237
-
MATSUO M, HASHIMOTO M, SUZUKI J, IWANAMI K, TOMOI M, SHIMOMURA K: Difference between normal and WHHL rabbits in susceptibility to the adrenal toxicity of an acyl-CoA:cholesterol acyltransferase inhibitor, FR 145237. Toxicol. Appl. Pharmacol. (1996) 140(2):387-392.
-
(1996)
Toxicol. Appl. Pharmacol
, vol.140
, Issue.2
, pp. 387-392
-
-
Matsuo, M.1
Hashimoto, M.2
Suzuki, J.3
Iwanami, K.4
Tomoi, M.5
Shimomura, K.6
-
44
-
-
0035865448
-
Lack of toxic effects of F 12511, a novel potent inhibitor of acyl-coenzyme A: Cholesterol O-acyltransferase, on human adrenocortical cells in culture
-
JUNQUERO D, PILON A, CARILLA-DURAND E et al.: Lack of toxic effects of F 12511, a novel potent inhibitor of acyl-coenzyme A: cholesterol O-acyltransferase, on human adrenocortical cells in culture. Biochem. Pharmacol. (2001) 61(4):387-398.
-
(2001)
Biochem. Pharmacol
, vol.61
, Issue.4
, pp. 387-398
-
-
Junquero, D.1
Pilon, A.2
Carilla-Durand, E.3
-
45
-
-
15644364732
-
Alpha-substituted malonester amides: Tools to define the relationship between ACAT inhibition and adrenal toxicity
-
SLISKOVIC DR, PICARD JA, O'BRIEN PM et al.: Alpha-substituted malonester amides: tools to define the relationship between ACAT inhibition and adrenal toxicity. J. Med. Chem. (1998) 41(5):682-690.
-
(1998)
J. Med. Chem
, vol.41
, Issue.5
, pp. 682-690
-
-
Sliskovic, D.R.1
Picard, J.A.2
O'Brien, P.M.3
-
46
-
-
0032539756
-
Biochemical evidence for oligomerization of rat adrenal acyl-coenzyme A:cholesterol acyltransferase
-
KAWASAKI T, MIYAZAKI A, HAKAMATA H, MATSUDA H, HORIUCHI S: Biochemical evidence for oligomerization of rat adrenal acyl-coenzyme A:cholesterol acyltransferase. Biochem. Biophys. Res. Commun. (1998) 244(2):347-352.
-
(1998)
Biochem. Biophys. Res. Commun
, vol.244
, Issue.2
, pp. 347-352
-
-
Kawasaki, T.1
Miyazaki, A.2
Hakamata, H.3
Matsuda, H.4
Horiuchi, S.5
-
47
-
-
0035124368
-
Preclinical safety evaluation of avasimibe in beagle dogs: An ACAT inhibitor with minimal adrenal effects
-
ROBERTSON DG, BREIDER MA, MILAD MA: Preclinical safety evaluation of avasimibe in beagle dogs: An ACAT inhibitor with minimal adrenal effects. Toxicol. Sci. (2001) 59:324-334.
-
(2001)
Toxicol. Sci
, vol.59
, pp. 324-334
-
-
Robertson, D.G.1
Breider, M.A.2
Milad, M.A.3
-
48
-
-
0011395935
-
Dose dependent induction of oral midazolam metabolism by avasimibe
-
MILAD MA, STERN R, STRENKOSHKI-NIX LC, LATHIA CD: Dose dependent induction of oral midazolam metabolism by avasimibe. Clin. Pharmacol. Ther. (2000) 67(2):136.
-
(2000)
Clin. Pharmacol. Ther
, vol.67
, Issue.2
, pp. 136
-
-
Milad, M.A.1
Stern, R.2
Strenkoshki-Nix, L.C.3
Lathia, C.D.4
-
49
-
-
0034965751
-
Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia
-
INSULL W, KOREN M, DAVIGNON J et al.: Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia. Atherosclerosis (2001) 157:137-144.
-
(2001)
Atherosclerosis
, vol.157
, pp. 137-144
-
-
Insull, W.1
Koren, M.2
Davignon, J.3
-
50
-
-
0034023061
-
Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase
-
ACCAD M, SMITH SJ, NEWLAND DL et al.: Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase. J. Clin. Invest. (2000) 105(6):711-719.
-
(2000)
J. Clin. Invest
, vol.105
, Issue.6
, pp. 711-719
-
-
Accad, M.1
Smith, S.J.2
Newland, D.L.3
-
51
-
-
0035096678
-
Preferential pharmacological inhibition of macrophage ACAT increases plaque formation in mouse and rabbit models of atherogenesis
-
PERRY S, LEGENDRE C, MATSUURA A et al.: Preferential pharmacological inhibition of macrophage ACAT increases plaque formation in mouse and rabbit models of atherogenesis. Atherosclerosis (2001) 155(2):359-370.
-
(2001)
Atherosclerosis
, vol.155
, Issue.2
, pp. 359-370
-
-
Perry, S.1
Legendre, C.2
Matsuura, A.3
-
53
-
-
0034795651
-
Acyl-coenzyme A: Cholesterol acyltransferase modulates the generation of the anyloid beta-peptide
-
PUGLIELLI L, KONOPKA G, PACKCHUNG E et al.: Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the anyloid beta-peptide. Nat. Cell Biol. (2001) 10:905-912.
-
(2001)
Nat. Cell Biol
, vol.10
, pp. 905-912
-
-
Puglielli, L.1
Konopka, G.2
Packchung, E.3
|